GLP-1 agonist, SARM, semaglutide 5mg vial

Semaglutide 5mg vial is an injectable version of semaglutide, an analog of the human glucagon-like peptide-1 (GLP-1) receptor agonist, indicated for the treatment of type II diabetes. When administered subcutaneously, it helps reduce glycosylated hemoglobin (HbA1c) levels and fasting plasma glucose concentrations to improve glycemic control in type II diabetic patients. Semaglutide 5mg vial is…